|
1
|
Ley B, Collard HR and King TE Jr: Clinical
course and prediction of survival in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 183:431–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Povedano JM, Martinez P, Flores JM, Mulero
F and Blasco MA: Mice with Pulmonary Fibrosis Driven by Telomere
Dysfunction. Cell Rep. 12:286–299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Selman M and Pardo A: Role of epithelial
cells in idiopathic pulmonary fibrosis: From innocent targets to
serial killers. Proc Am Thorac Soc. 3:364–372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Willis BC, Liebler JM, Luby-Phelps K,
Nicholson AG, Crandall ED, du Bois RM and Borok Z: Induction of
epithelial-mesenchymal transition in alveolar epithelial cells by
transforming growth factor-beta1: Potential role in idiopathic
pulmonary fibrosis. Am J Pathol. 166:1321–1332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hou J, Shi J, Chen L, Lv Z, Chen X, Cao H,
Xiang Z and Han X: M2 macrophages promote myofibroblast
differentiation of LR-MSCs and are associated with pulmonary
fibrogenesis. Cell Commun Signal. 16:892018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saito S, Zhuang Y, Shan B, Danchuk S, Luo
F, Korfei M, Guenther A and Lasky JA: Tubastatin ameliorates
pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. PLoS
One. 12:e01866152017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li S, Geng J, Xu X, Huang X, Leng D, Jiang
D, Liang J, Wang C, Jiang D and Dai H: miR-130b-3p Modulates
Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting
IGF-1. PLoS One. 11:e01504182016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei S, Wang Q, Zhou H, Qiu J, Li C, Shi C,
Zhou S, Liu R and Lu L: miR-455-3p Alleviates Hepatic Stellate Cell
Activation and Liver Fibrosis by Suppressing HSF1 Expression. Mol
Ther Nucleic Acids. 16:758–769. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu XJ, Gong Z, Li SJ, Jia HP and Li DL:
Long non-coding RNA Hottip modulates high-glucose-induced
inflammation and ECM accumulation through miR-455-3p/WNT2B in mouse
mesangial cells. Int J Clin Exp Pathol. 12:2435–2445.
2019.PubMed/NCBI
|
|
12
|
Yu F, Jiang Z, Chen B, Dong P and Zheng J:
NEAT1 accelerates the progression of liver fibrosis via regulation
of microRNA-122 and Kruppel-like factor 6. J Mol Med (Berl).
95:1191–1202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang S, Xu Y, Ge X, Xu B, Peng W, Jiang
X, Shen L and Xia L: Long noncoding RNA NEAT1 accelerates the
proliferation and fibrosis in diabetic nephropathy through
activating Akt/mTOR signaling pathway. J Cell Physiol.
234:11200–11207. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yao W, Li Y, Han L, Ji X, Pan H, Liu Y,
Yuan J, Yan W and Ni C: The CDR1as/miR-7/TGFBR2 Axis Modulates EMT
in Silica-Induced Pulmonary Fibrosis. Toxicol Sci. 166:465–478.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao X, Sun J, Chen Y, Su W, Shan H, Li Y,
Wang Y, Zheng N, Shan H and Liang H: lncRNA PFAR Promotes Lung
Fibroblast Activation and Fibrosis by Targeting miR-138 to Regulate
the YAP1-Twist Axis. Mol Ther. 26:2206–2217. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang X, Cheng Z, Dai L, Jiang T, Jia L,
Jing X, An L, Wang H and Liu M: Knockdown of Long Noncoding RNA H19
Represses the Progress of Pulmonary Fibrosis through the
Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA
140. Mol Cell Biol. 39:e00143–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu Q, Han L, Yan W, Ji X, Han R, Yang J,
Yuan J and Ni C: miR-489 inhibits silica-induced pulmonary fibrosis
by targeting MyD88 and Smad3 and is negatively regulated by lncRNA
CHRF. Sci Rep. 6:309212016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun J, Su W, Zhao X, Shan T, Jin T, Guo Y,
Li C, Li R, Zhou Y, Shan H, et al: lncRNA PFAR contributes to
fibrogenesis in lung fibroblasts through competitively binding to
miR-15a. Biosci Rep. 39:BSR201902802019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao X, Sun J, Chen Y, Su W, Shan H, Li Y,
Wang Y, Zheng N, Shan H and Liang H: lncRNA PFAR Promotes Lung
Fibroblast Activation and Fibrosis by Targeting miR-138 to Regulate
the YAP1-Twist Axis. Mol Ther. 26:2206–2217. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hao X, Du Y, Qian L, Li D and Liu X:
Upregulation of long noncoding RNA AP003419.16 predicts high risk
of aging associated idiopathic pulmonary fibrosis. Mol Med Rep.
16:8085–8091. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li JH, Zhang SQ, Qiu XG, Zhang SJ, Zheng
SH and Zhang DH: Long non-coding RNA NEAT1 promotes malignant
progression of thyroid carcinoma by regulating miRNA-214. Int J
Oncol. 50:708–716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Wang S, Li Z, Long X, Guo Z, Zhang
G, Zu J, Chen Y and Wen L: Retracted: NEAT1 induces
epithelial-mesenchymal transition and 5-FU resistance through the
miR-129/ZEB2 axis in breast cancer. FEBS Lett. Nov 1–2016.(Epub
ahead of print). doi: 10.1002/1873-3468.12474.
|
|
24
|
Liu T, Zhang Y, Liu W and Zhao J: lncRNA
NEAT1 Regulates the Development of Parkinson's Disease by Targeting
AXIN1 Via Sponging miR-212-3p. Neurochem Res. Nov 26–2020.(Epub
ahead of print). doi: 10.1007/s11064-020-03157-1. View Article : Google Scholar
|
|
25
|
Liu L, Liu F, Sun Z, Peng Z, You T and Yu
Z: lncRNA NEAT1 promotes apoptosis and inflammation in LPS-induced
sepsis models by targeting miR-590-3p. Exp Ther Med. 20:3290–3300.
2020.PubMed/NCBI
|
|
26
|
Dong C, Gongora R, Sosulski ML, Luo F and
Sanchez CG: Regulation of transforming growth factor-beta1
(TGF-β1)-induced pro-fibrotic activities by circadian clock gene
BMAL1. Respir Res. 17:42016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshida M, Romberger DJ, Illig MG,
Takizawa H, Sacco O, Spurzem JR, Sisson JH, Rennard SI and Beckmann
JD: Transforming growth factor-beta stimulates the expression of
desmosomal proteins in bronchial epithelial cells. Am J Respir Cell
Mol Biol. 6:439–445. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma J, Zhao N, Du L and Wang Y:
Downregulation of lncRNA NEAT1 inhibits mouse mesangial cell
proliferation, fibrosis, and inflammation but promotes apoptosis in
diabetic nephropathy. Int J Clin Exp Pathol. 12:1174–1183.
2019.PubMed/NCBI
|
|
29
|
Jin SS, Lin XF, Zheng JZ, Wang Q and Guan
HQ: lncRNA NEAT1 regulates fibrosis and inflammatory response
induced by nonalcoholic fatty liver by regulating miR-506/GLI3. Eur
Cytokine Netw. 30:98–106. 2019.PubMed/NCBI
|
|
30
|
Li X, Ye S and Lu Y: Long non-coding RNA
NEAT1 overexpression associates with increased exacerbation risk,
severity, and inflammation, as well as decreased lung function
through the interaction with microRNA-124 in asthma. J Clin Lab
Anal. 34:e230232020.PubMed/NCBI
|
|
31
|
Zhao Y, Yan M, Yun Y, Zhang J, Zhang R, Li
Y, Wu X, Liu Q, Miao W and Jiang H: MicroRNA-455-3p functions as a
tumor suppressor by targeting eIF4E in prostate cancer. Oncol Rep.
37:2449–2458. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng J, Lin Z, Zhang L and Chen H:
MicroRNA-455-3p Inhibits Tumor Cell Proliferation and Induces
Apoptosis in HCT116 Human Colon Cancer Cells. Med Sci Monit.
22:4431–4437. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhan T, Huang X, Tian X, Chen X, Ding Y,
Luo H and Zhang Y: Downregulation of MicroRNA-455-3p Links to
Proliferation and Drug Resistance of Pancreatic Cancer Cells via
Targeting TAZ. Mol Ther Nucleic Acids. 10:215–226. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo J, Liu C, Wang W, Liu Y, He H, Chen C,
Xiang R and Luo Y: Identification of serum miR-1915-3p and
miR-455-3p as biomarkers for breast cancer. PLoS One.
13:e02007162018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou Y and Chai X: Protective effect of
bicyclol against pulmonary fibrosis via regulation of
microRNA-455-3p in rats. J Cell Biochem. 121:651–660. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu J, Liu J, Ding Y, Zhu M, Lu K, Zhou J,
Xie X, Xu Y, Shen X, Chen Y, et al: MiR-455-3p suppresses renal
fibrosis through repression of ROCK2 expression in diabetic
nephropathy. Biochem Biophys Res Commun. 503:977–983. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
